Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
11.98
-0.07 (-0.58%)
At close: Oct 23, 2026, 4:00 PM EDT
11.80
-0.18 (-1.50%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Korro Bio Revenue
Korro Bio had revenue of $2.38M in the twelve months ending June 30, 2026, down -62.08% year-over-year. In the year 2025, Korro Bio had annual revenue of $6.39M with 181.46% growth. That makes Korro Bio the 42,038th largest company in the world by revenue and 5,697th in the United States.
Revenue (ttm)
$2.38M
Revenue Growth
-62.08%
P/S Ratio
74.06
Revenue / Employee
$41,789
Employees
57
Market Cap
176.41M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.39M | 4.12M | 181.46% |
| Dec 31, 2024 | 2.27M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Compugen | 74.00M |
| Invivyd | 58.37M |
| Sutro Biopharma | 45.70M |
| Alpha Cognition | 15.26M |
| Whitehawk Therapeutics | 7.15M |
| Entrada Therapeutics | 4.69M |
| Oramed Pharmaceuticals | 2.00M |
KRRO News
- 3 days ago - Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency - GlobeNewsWire
- 3 days ago - Korro Bio management to meet virtually with Oppenheimer - TheFly
- 8 days ago - Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - Korro Bio management to meet with Piper Sandler - TheFly
- 19 days ago - Korro Bio doses first cohort of participants in KRRO-121 trial - TheFly
- 19 days ago - Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121 - GlobeNewsWire
- 6 weeks ago - Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 1 month ago - Korro to Participate in Upcoming Investor Conferences - GlobeNewsWire